Tavi Nathanson

1PUBLICATIONS
11CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|May 30, 2017
Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis.

Alexandra Snyder, Tavi Nathanson, Samuel A Funt

Pageof 1

Frequent Collaborators

1 joint publications

Alexandra Snyder

1 joint publications

Jacqueline Buros Novik

1 joint publications

Matthew D Hellmann

1 joint publications

Eliza Chang

1 joint publications

Bulent Arman Aksoy

1 joint publications

Marissa Vignali

1 joint publications

Harlan S Robins

1 joint publications

Taha Merghoub

1 joint publications

Jeff Hammerbacher

1 joint publications

Jonathan E Rosenberg

Frequent Collaborators

1 joint publications

Alexandra Snyder

1 joint publications

Jacqueline Buros Novik

1 joint publications

Matthew D Hellmann

1 joint publications

Eliza Chang

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.6K
See more related videos

Top Related Videos

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on : Feb 07, 2021

5.6K
See more related videos